These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4920411)

  • 1. Clinical stages in sulfone treatment of leprosy.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriological status (point prevalence) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Almeida JO; Araujo Arantes MA
    Bull World Health Organ; 1975; 52(1):57-62. PubMed ID: 764995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Marques RM
    Int J Lepr Other Mycobact Dis; 1970; 38(3):250-63. PubMed ID: 4993550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic and histomorphologic features of responsiveness in patients with leprosy at different stages of treatment].
    Strukov AI; Babaiants RS; Shakhtmeĭster IIa; Kopieva TN; Goloschapov NM
    Vestn Dermatol Venerol; 1972 Oct; 46(10):8-12. PubMed ID: 4569353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
    Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
    Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
    Jacobson RR; Trautman JR
    Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 8. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of leprosy--effect of the anti-leprotic agent on the growth of acid-fast bacilli in cutaneous and mucous tissue].
    Hirano E
    Iryo; 1972 Mar; 26(3):243-53. PubMed ID: 4554827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Leprosy].
    Languillon J
    Acta Leprol; 1978; (71-72):1-168. PubMed ID: 104538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium leprae in skin and nasal scrapings during sulfone treatment; a review of 146 cases.
    BYERS JL; WOLCOTT RR
    Int J Lepr; 1954; 22(3):285-7. PubMed ID: 13232776
    [No Abstract]   [Full Text] [Related]  

  • 13. Growing points in leprosy research. 2. Epidemiology.
    Meade TW
    Lepr Rev; 1974 Mar; 45(1):15-21. PubMed ID: 4602616
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leprosy research].
    Luger A
    Wien Klin Wochenschr; 1971 Mar; 83(10):161-5. PubMed ID: 4327066
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with 4,4'-diacetyldiaminodiphenylsulfone (DADDS) of leprosy patients in the Karimui, New Guinea.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1971 May; 20(3):495-501. PubMed ID: 4932529
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of recent abstracts. 8. Leprosy.
    Browne SG
    Trop Dis Bull; 1970 Sep; 67(9):1065-73. PubMed ID: 4321145
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in experimental leprosy.
    Rees RJ
    Bibl Tuberc; 1970; 26():189-232. PubMed ID: 4244234
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
    Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
    Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.